What is Actos?
The chemical name for Actos is Pioglitazone. Actos is a widely-used treatment method for Type 2 diabetes – a condition in which the body does not use insulin normally, and therefore cannot control the amount of sugar in the blood.
Actos is in a class of medications called thiazolidinediones. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels. Actos is not used to treat Type 1 diabetes – a condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood.
Recent scientific studies have shown Actos to increase the risk of heart attacks and heart failure. In addition, Actos has been linked with an increased risk of bladder tumors. Actos was withdrawn from the market in France and Germany, and recently the FDA updated the warnings on Actos to include an increased risk of bladder cancer.
Actos was sold in three different dosages: 15 mg, 30 mg, and 45 mg. In addition to Actos, Pioglitazone was combined with other drugs and marketed under the following trade names:
1. ActoplusMet (containing Pioglitazone and Metformin);
2. Competact (containing Pioglitazone and Metformin); and
3. Duetact (containing Pioglitazone and Glimepiride).
Help if You've Used Actos
At O'Hanlon, McCollom & Demerath, our products liability attorneys understand that your injuries may be due to a side effect of Actos. Our in-depth knowledge and experience make us uniquely well-qualified to handle even the most complex Actos cases. If you suspect you have an Actos injury such as heart failure, heart attack, or bladder tumor and need to talk to a legal professional, contact us today.